Basilea gibt positive Topline-Ergebnisse aus Phase-2-Studie FIDES-01 mit Derazantinib bei Patienten mit Gallengangkrebs (iCCA) und Fusionen des FGFR2-Gens bekannt
February 10, 2021 01:15 ET
|
Basilea Pharmaceutica AG
Klinischer Wirksamkeitsnachweis (Proof of Concept) für Derazantinib-Monotherapie bei FGFR2-Genfusions-positivem iCCA 20.4% objektive Ansprechrate und 6.6 Monate (Median) progressionsfreies Überleben...
Dr. Jamie Dwyer, Professor of Medicine at Vanderbilt University Joins Draganfly Board of Advisors
February 09, 2021 09:15 ET
|
Draganfly Inc
Los Angeles, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems...
Anhaltend starke Cresemba® (Isavuconazol) Umsätze lösen USD 10 Mio. Meilensteinzahlung von Pfizer an Basilea aus
February 09, 2021 01:15 ET
|
Basilea Pharmaceutica AG
Basel, 09. Februar 2021 Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass die von Pfizer mit dem Antimykotikum Cresemba® (Isavuconazol) in Europa und Israel erzielten Umsätze die Schwelle...
Continued strong Cresemba® (isavuconazole) sales trigger milestone from Pfizer to Basilea of USD 10 million
February 09, 2021 01:15 ET
|
Basilea Pharmaceutica AG
Basel, Switzerland, February 09, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that sales of the antifungal Cresemba® (isavuconazole) by Pfizer in Europe and Israel exceeded the...
Globex Mining Enterprises to Participate in Renmark’s Virtual Non-Deal Roadshow Series on February 11, 2021
February 08, 2021 09:00 ET
|
Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, Feb. 08, 2021 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz...
Draganfly Inc. Interview to Air on Bloomberg International on the RedChip Money Report
February 05, 2021 09:15 ET
|
Draganfly Inc
Los Angeles, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems...
Pre-Feasibility Study Update - Alpala Project, Cascabel Concession, Ecuador
February 05, 2021 08:00 ET
|
Cornerstone Capital Resources Inc.
OTTAWA, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) is pleased to announce the following...
Talladega College Selects Draganfly to Provide its Vital Intelligence Technology
February 04, 2021 09:15 ET
|
Draganfly Inc
Vital Intelligence’s Vital Sign Screening Detects Potential Symptoms of COVID-19 Los Angeles, CA., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8)...
Routemaster Capital Announces Disposition of Shares in Sulliden Mining Capital Inc.
February 03, 2021 17:00 ET
|
Routemaster Capital Inc.
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (“Routemaster” or the “Company”) (NEO: DEFI) (GR: RMJR) announces that it has disposed of 9,091,500 common shares in the capital...
Routemaster Capital Announces 101.6 Percent Increase in Treasury Balance in Leading DeFi Protocols and Announces Thibaut Ceyrolle, Snowflake EMEA Founder, as Special Advisor for Cloud Infrastructure; Olivier Roussy Newton Appointed as EIR
February 03, 2021 07:00 ET
|
Routemaster Capital Inc.
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Routemaster Capital Inc. (the “Company” or “Routemaster”) (NEO: DEFI) (GR: RMJR), a Canadian decentralized finance company, is pleased to announce its...